62
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells

, , , , , , , , , & show all
Pages 3925-3932 | Published online: 28 Nov 2016

References

  • JainAKBlakePCordyPGargAXGlobal trends in rates of peritoneal dialysisJ Am Soc Nephrol201223353354422302194
  • MehrotraRChiuYWKalantar-ZadehKBargmanJVoneshESimilar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal diseaseArch Intern Med2011171211011820876398
  • BoatengEAEastLThe impact of dialysis modality on quality of life: a systematic reviewJ Ren Care201137419020022035363
  • ZhangAHChengLTZhuNSunLHWangTComparison of quality of life and causes of hospitalization between hemodialysis and peritoneal dialysis patients in ChinaHealth Qual Life Outcomes200754917678543
  • MaiorcaRBrunoriGZubaniRPredictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal studyNephrol Dial Transplant19951012229523058808229
  • BargmanJMThorpeKEChurchillDNCPDS GroupRelative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA studyJ Am Soc Nephrol200112102158216211562415
  • TermorshuizenFKorevaarJCDekkerFWvan ManenJGBoeschotenEWKredietRTNECOSAD Study GroupThe relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2Am J Kidney Dis20034161293130212776283
  • MoistLMPortFKOrzolSMPredictors of loss of residual renal function among new dialysis patientsJ Am Soc Nephrol200011355656410703680
  • JorresATopleyNGahlGMBiocompatibility of peritoneal dialysis fluidsInt J Artif Organs199215279831555880
  • Nilsson-ThorellCBMuscaluNAndrenAHKjellstrandPTWieslanderAPHeat sterilization of fluids for peritoneal dialysis gives rise to aldehydesPerit Dial Int19931332082138369351
  • HolmesCJGlucotoxicity in peritoneal dialysis – solutions for the solution!Adv Chronic Kidney Dis200714326927817603981
  • Diaz-BuxoJAGotloibLAgents that modulate peritoneal membrane structure and functionPerit Dial Int2007271163017179504
  • PandolfiADe FilippisEAChronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modificationsGenes Nutr20072219520818850175
  • Di FulvioPPandolfiAFormosoGFeatures of endothelial dysfunction in umbilical cord vessels of women with gestational diabetesNutr Metab Cardiovasc Dis201424121337134525438716
  • KimYLChoJHChoiJYKimCDParkSHSystemic and local impact of glucose and glucose degradation products in peritoneal dialysis solutionJ Ren Nutr201323321822223510669
  • BurkartJMetabolic consequences of peritoneal dialysisSemin Dial200417649850415660581
  • CaballoCPalomoMCasesANFkappaB in the development of endothelial activation and damage in uremia: an in vitro approachPLoS One201278e4337422937042
  • HolmesCMujaisSGlucose sparing in peritoneal dialysis: implications and metricsKidney Int Suppl2006103S104S10917080098
  • Di PietroNGiardinelliASirolliVNitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patientsMol Cell Biochem20164171–215516727206740
  • ArduiniABonominiMSavicaVAmatoAZammitVCarnitine in metabolic disease: potential for pharmacological interventionPharmacol Ther2008120214915618793670
  • BonominiMPandolfiADi LiberatoLl-carnitine is an osmotic agent suitable for peritoneal dialysisKidney Int201180664565421525850
  • BonominiMDi LiberatoLDel RossoGEffect of an l-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trialAm J Kidney Dis201362592993823725973
  • GaggiottiEArduiniABonominiMPrevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits)Int J Artif Organs200528217718715770606
  • BazzatoGColiULandiniSXylitol as osmotic agent in CAPD: an alternative to glucose for uremic diabetic patients?Trans Am Soc Artif Intern Organs1982282802866761936
  • LiveseyGHealth potential of polyols as sugar replacers, with emphasis on low glycaemic propertiesNutr Res Rev200316216319119087388
  • Di PaoloNSacchiGAtlas of peritoneal histologyPerit Dial Int200020Suppl 3S5S96
  • ThorgeirssonGRobertsonALJrThe vascular endothelium-pathobiologic significanceAm J Pathol1978933803848362947
  • OzuguzUIsikSBerkerDGestational diabetes and subclinical inflammation: evaluation of first year postpartum outcomesDiabetes Res Clin Pract201194342643321917349
  • WangAYConsequences of chronic inflammation in peritoneal dialysisSemin Nephrol201131215917121439430
  • StenvinkelPKettelerMJohnsonRJIL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia – the good, the bad, and the uglyKidney Int20056741216123315780075
  • LocatelliFCanaudBEckardtKUStenvinkelPWannerCZoccaliCOxidative stress in end-stage renal disease: an emerging threat to patient outcomeNephrol Dial Transplant20031871272128012808161
  • SchneiderASSchettlerAMarkowskiAAssessment of xylitol serum levels during the course of parenteral nutrition including xylitol in intensive care patients: a case control studyClin Nutr201433348348823916161
  • PengTWongNKChenXMolecular imaging of peroxynitrite with HKGreen-4 in live cells and tissuesJ Am Chem Soc201413633117281173425058034
  • LanutiPRottaGAlmiciCEndothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord bloodCytometry A201689325927026305912
  • Di TomoPDi SilvestreSCordoneVGCentella asiatica and lipoic acid, or a combination thereof, inhibit monocyte adhesion to endothelial cells from umbilical cords of gestational diabetic womenNutr Metab Cardiovasc Dis201525765966626026207
  • LanutiPMarchisioMCantilenaSA flow cytometry procedure for simultaneous characterization of cell DNA content and expression of intracellular protein kinase C-zetaJ Immunol Methods20063151–2374816945385
  • DaviesSJPhillipsLGriffithsAMRussellLHNaishPFRussellGIWhat really happens to people on long-term peritoneal dialysis?Kidney Int1998546220722179853287
  • ChaudharyKKhannaRBiocompatible peritoneal dialysis solutions: do we have one?Clin J Am Soc Nephrol20105472373220093342
  • JonesMHagenTBoyleCATreatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient studyAm J Kidney Dis19983257617699820445
  • JohnsonDWAgarJCollinsJRecommendations for the use of icodextrin in peritoneal dialysis patientsNephrology (Carlton)2003811715012742
  • LiPKCulletonBFArizaARandomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patientsJ Am Soc Nephrol201324111889190023949801
  • American Diabetes Association(7) Approaches to glycemic treatmentDiabetes Care201538Suppl 1S41S4825537707
  • TaddeiSCombination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?Am J Cardiovasc Drugs201515318519425850749
  • SeoEYAnSHChoJHEffect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trialsPerit Dial Int201434772473125185015
  • CookerLALuneburgPFaictDChooCHolmesCJReduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bagsPerit Dial Int19971743733789284465
  • RossRAtherosclerosis – an inflammatory diseaseN Engl J Med199934021151269887164
  • GearingAJNewmanWCirculating adhesion molecules in diseaseImmunol Today199314105065127506035
  • BonominiMRealeMSantarelliPStuardSSettefratiNAlbertazziASerum levels of soluble adhesion molecules in chronic renal failure and dialysis patientsNephron19987943994079689154
  • WangAYLamCWWangMCirculating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patientsAm J Kidney Dis200545471572915806475
  • ChoiHYLeeJEHanSHAssociation of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patientsNephrol Dial Transplant20102541266127119926717
  • KishorePKehlenbrinkSHuMXylitol prevents NEFA-induced insulin resistance in ratsDiabetologia20125561808181222460760